Published June 2001
by Uppsala Universitet .
Written in English
|Series||Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine, 1029|
|The Physical Object|
|Number of Pages||46|
Louis F. Martin, M.D. Professor of Surgery Department of Surgery Louisiana State University Health Sciences Center New Orleans, LA Dr. Martin is also at the forefront of this subspecialty, and serves as one of the chairpersons on an American College of Surgeon’s sub-committee for the surgical treatment of morbid : $ The Surgical Treatment of Morbid Obesity: Economic, Psychosocial, Ethical, Preventive, Medical Aspects of Health Care Article (PDF Available) in The Yale journal of biology and medicine 56(3) Thus, the treatment of obesity and its co-morbidities requires a multidisciplinary approach, taking into account epidemiological, clinical, nutritional and genetic aspects of morbid obesity in the pediatric age group. This volume discusses both conventional therapy and surgical options for morbid obesity in the pediatric age : Springer-Verlag Wien. Obesity is a complex, multifactorial disease that develops from the interaction of genetic, metabolic, social, behavioral, and cultural factors. 1 This disease has a significant impact on the health, psychosocial well-being, longevity, and quality of life of those affected. 2 Despite the possible occurrence of perioperative and, more frequently, later complications, bariatric surgery can.
Download Citation | On , Dong Kim and others published Surgical Treatment of Obesity | Find, read and cite all the research you need on ResearchGate. Surgical treatment of morbid, familial, juvenile-onset obesity in a year-old, pound, mother of three children by jejunoileal bypass was subsequently converted to gastric bypass. The resulting weight loss of pounds resulted in personality changes and . Surgical treatment of obesity: a review of our experience and an analysis of published reports. Int J Obes. ; 1 (4)– Coughlin K, Bell RM, Bivins BA, Wrobel S, Griffen WO., Jr Preoperative and postoperative assessment of nutrient intakes in patients who have undergone gastric bypass surgery. Arch Surg. Jul; (7)– Morbid obesity, which is an indication for surgical treatment, is considered to be the state when (1) the BMI on its own exceeds 40 kg/m 2 or (2) the BMI is over 35 kg/m 2 and is accompanied by comorbidities. Among them most often observed are: type 2 diabetes, hypertension, dyslipidaemia, osteoarthritis, sleep apnoea and others.
Morbid obesity significantly reduces life span and is associated with much co‐morbid pathology. Diet, behavioural therapy and drug therapy are largely unsuccessful. Surgical treatment offers the best hope. This review summarizes the rationale for treatment and the available surgical options. The exhaustion of conservative treatment is defined as follows, for the purpose of determining the indication for obesity surgery: if the patient has been unable to achieve a loss of >15% of the initial weight (BMI – kg/m²), or >20% of the initial weight (BMI ≥ 40 kg/m²), despite having undergone a comprehensive lifestyle. An important aspect of the decision faced by a patient seeking surgical treatment for obesity is the risk inherent to each surgical procedure. VSG requires fewer suture lines than RYGB and no anastomoses, suggesting that postoperative complications may be reduced following VSG as compared with RYGB. 3rd Avenue South Birmingham, AL () Surgical Treatment of Morbid Obesity. BARIATRIC (WEIGHT LOSS) SURGERY PROGRAM. PROSPECTIVE AND NEW PATIENT INFORMATION. Richard Stahl, MD Jayleen Grams, MD, PhD.